Group 1 - The upcoming IPO of Shougang Longze represents a rare investment opportunity in the Hong Kong stock market, particularly in the carbon capture, utilization, and storage (CCUS) sector, which is expected to invigorate ESG concept stocks [1] - The market environment since 2025 has been favorable for IPOs, with notable examples like Blook and Mixue Ice City demonstrating strong investor sentiment and valuation potential for fundamentally sound companies [2] - The CCUS industry is projected to see significant growth, with global investment expected to rise from $12.6 billion in 2023 to $76.8 billion by 2028, reflecting a compound annual growth rate (CAGR) of 43.5% [3][6] Group 2 - Shougang Longze is the first company in the CCUS industry to commercialize low-carbon product production using validated synthetic biology technology, providing it with a first-mover advantage and substantial growth potential [3][10] - The demand for carbon capture in China is anticipated to increase more than 20 times by 2040, from approximately 20 million tons per year in 2025 to about 630 million tons per year [3] - The company's business model includes the sale of ethanol and microbial protein, as well as comprehensive low-carbon solutions for industrial clients, positioning it uniquely in the market [3][10] Group 3 - The synthetic biology technology utilized by Shougang Longze is expected to be a primary technological pathway for the future development of the CCUS industry, enhancing carbon emission conversion efficiency and aligning with ESG development needs [9] - Shougang Longze's technology is the only verified synthetic biology technology in the CCUS sector, providing a significant competitive advantage and establishing a comprehensive research and development system [10][11] - The company has successfully implemented large-scale production facilities and holds 241 authorized patents, with an additional 102 patents pending, creating a robust intellectual property framework [10][11] Group 4 - Overall, Shougang Longze is positioned as a benchmark in the Hong Kong stock market, combining industry growth potential, technological leadership, and market validation, making it a unique investment opportunity [12]

Core Viewpoint - Shougang Longze Technology Co., Ltd. has delayed its global offering and listing plan, returning application funds, originally scheduled for July 9 on the Hong Kong Stock Exchange [1][2]. Company Overview - Shougang Longze focuses on the carbon capture, utilization, and storage (CCUS) industry, producing low-carbon products such as ethanol and microbial protein, and providing comprehensive low-carbon solutions [4]. - The company’s ethanol can be used as fuel and as a raw material for various products, while its microbial protein is the first novel feed protein raw material in China [4]. Financial Performance - In the previous year, Shougang Longze reported revenue of 560 million RMB, a year-on-year decline of 4.9%, with a net loss attributable to shareholders of 140 million RMB, an increase of 1.1 times [6]. - Financial projections indicate a revenue increase to 592.6 million RMB in 2023, followed by a slight decrease to 563.6 million RMB in 2024 [7]. Fund Utilization Plan - The company plans to allocate approximately 37.9% of the net proceeds for the construction and development of SAF production facilities in Baotou, Inner Mongolia, 21.2% for the second phase facility in Hebei, and 11.4% for research and development of strains, production equipment, and smart production management systems [8].

Group 1 - The company, Shougang Longze, plans to conduct an IPO from June 30 to July 4, 2025, offering 20.1598 million H-shares, with 10% allocated for Hong Kong and 90% for international sales, at a price not exceeding HKD 18.88 per share and not lower than HKD 14.50 per share [1] - The company specializes in the Carbon Capture, Utilization, and Storage (CCUS) industry, focusing on producing low-carbon products such as ethanol and microbial protein through carbon capture and utilization technology [1] - Since its establishment in 2011, the company has made significant breakthroughs in applying its proprietary synthetic biology technology for industrial production, including the world's first industrial facility that uses carbon-containing industrial waste gas from steel and ferroalloy plants for fermentation to produce ethanol and microbial protein [1] Group 2 - The company's revenue grew rapidly, increasing by 52.1% from RMB 389.5 million in 2022 to RMB 593 million in 2023, but then decreased by 4.9% to RMB 564 million in 2024 [2] - The company reported losses of RMB 23.9 million, RMB 110 million, and RMB 246 million for the years ending December 31, 2022, 2023, and 2024, respectively [2] - The company's EBITDA (non-IFRS measure) for the years ending December 31, 2022, 2023, and 2024 were RMB 33.1 million, RMB 14.2 million, and -RMB 82.5 million, respectively [2] Group 3 - The company intends to use the net proceeds of HKD 284 million from the IPO for various purposes, including approximately 37.9% for developing SAF production facilities in Baotou, Inner Mongolia, and 21.2% for the second phase of production facilities in Hebei [3] - About 11.4% of the proceeds will be allocated for R&D of strains, production equipment, and smart production management systems to enhance production efficiency, while 14.1% will be used for technological upgrades of four production facilities [3] - The remaining proceeds will be used for new product development (5.3%) and general corporate purposes and working capital needs (10.0%) [3]

Core Viewpoint - Beijing Shougang Longze Technology Co., Ltd. (Shougang Longze) is focused on the carbon capture, utilization, and storage (CCUS) industry, aiming to produce low-carbon products through innovative technologies and provide comprehensive low-carbon solutions [3]. Company Overview - Shougang Longze is the only company in the global CCUS industry that has commercialized and scaled the production of low-carbon products using verified synthetic biology technology [3]. - The company has achieved significant innovations, including the world's first industrial facility that uses carbon-rich industrial waste gas from steel and ferroalloy plants to produce ethanol and microbial protein through fermentation [3]. - The company's ethanol can be used as fuel and as a raw material for products like perfumes, sportswear, detergents, and packaging materials, while its microbial protein is the first novel feed protein raw material in China [3]. Business Model - The primary revenue sources for the company include the sale of ethanol, microbial protein, and by-products such as biogas and crude alcohol, along with providing low-carbon comprehensive solutions to industrial clients [3]. Production Capacity - Shougang Longze operates four production facilities across three provinces in China, with a total annual production capacity of 210,000 tons of ethanol and 23,200 tons of microbial protein [3]. Market Opportunity - The global CCUS industry is projected to grow from an annual investment of $12.6 billion in 2023 to $76.8 billion by 2028, reflecting a compound annual growth rate (CAGR) of 43.5% [4]. - In China, the CCUS industry investment is expected to increase from RMB 21.6 billion in 2023 to RMB 99.3 billion by 2028, with a CAGR of 35.7% [4]. Customer Dependency - The company has a high dependency on a few major clients, with revenue from the top five clients accounting for 82.1%, 86.0%, and 78.9% of total revenue in the respective years [4]. - The largest client contributed 37.5%, 46.5%, and 26.3% to total revenue in the respective years [4]. Financial Performance - The company's revenue for the fiscal years 2022, 2023, and 2024 is approximately RMB 389.5 million, RMB 592.6 million, and RMB 563.6 million, respectively [5]. - The net losses for the same periods are RMB 23.9 million, RMB 110.1 million, and RMB 245.6 million, respectively [5].